BridgeMD
New treatment option for Advanced Solid Tumor
Official title SNV1521 in Participants With Advanced Solid Tumors
ClinicalTrials.gov ID: NCT06220864
What this study is testing
What is SNV1521?
SNV1521 is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for advanced solid tumor.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing a new medicine, SNV1521, for people with advanced cancers. The researchers want to find out if SNV1521 is safe, well-tolerated, and effective in treating solid tumors.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Advanced or metastatic solid tumor malignancy
- Evaluable or Measurable disease (RECIST 1.1 Criteria).
- ECOG Performance Status 0 or 1.
- Life expectancy \> 3 months
You likely can't join if
- History of other malignancy within the past 2 years
- Prior diagnosis of Myelodysplastic syndrome or Acute Myeloid Leukemia
- Significant cardiovascular disease within 6 months
- Significant gastrointestinal disease
- HIV infection with a CD4+ T-cell count \< 200 cells/μL and/or a detectable viral load
- Liver dysfunction
The study team makes the final eligibility decision.
Where it's taking place
- New Haven, Connecticut, United States
- Philadelphia, Pennsylvania, United States
- Nashville, Tennessee, United States
- Houston, Texas, United States
- West Valley City, Utah, United States
- Randwick, New South Wales, Australia
- Woolloongabba, Queensland, Australia
- Clayton, Victoria, Australia
- Melbourne, Victoria, Australia
- Crawley, Western Australia, Australia
- Brussels, Belgium
- Edegem, Belgium
- Ghent, Belgium
- Kortrijk, Belgium
- Calgary, Alberta, Canada
- Toronto, Ontario, Canada
- Bordeaux, France
- Lyon, France
- Villejuif, France
- Milan, Italy
+ 2 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New Haven, Connecticut, United States; Philadelphia, Pennsylvania, United States; Nashville, Tennessee, United States; Houston, Texas, United States; West Valley City, Utah, United States; Randwick, New South Wales, Australia and 16 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.